CytoReason (סיטוריזון)
Tel Aviv, Israel
CytoReason is focused on turning human clinical data into clear biology in order to deliver data-driven target discovery and drug development. The company uses its access to proprietary and public data, combined with machine learning technologies, to create innovative biological models of diseases, tissues, and drugs. Using its molecular-level disease models, CytoReason turns human clinical data into biology, mapping what the cells, genes, and proteins are doing in disease, tissue, and treatment environments. This enables the company to uncover disease and drug mechanisms of action and to put that biology to clinical use by delivering valuable IP in the form of novel targets, indications, combinations, and biomarkers.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2016
- Website
- cytoreason.com/
Categories
Disease Areas
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of CytoReason (סיטוריזון)?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now